Canada’s free ride on U.S. drug development may end soon
A shift in U.S. drug pricing could cut pharmaceutical profits, meaning less money for research and development
Read MoreA shift in U.S. drug pricing could cut pharmaceutical profits, meaning less money for research and development
Read MoreInstead of using scarce health-care dollars broadly, we should identify and support those Canadians falling through the cracks
Read MoreOur closed government-heavy system stands in stark contrast to other universal health-care systems that have shorter wait times
Read MoreWe’ve seen decades of policy paralysis, with provinces constantly under threat of penalty for exploring policy options
Read MoreWe should stop demonizing private clinics – and the patients who need them – and recognize that they’re part of the solution
Read More